Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific nTPM	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific nTPM	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific nTPM	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific nTPM	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific nTPM	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific nTPM	RNA tissue cell type enrichment	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific nTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific nTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Blood expression cluster	Tissue expression cluster	Cell line expression cluster	Single cell expression cluster	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	RNAsingleCellTypeSpecific
PAX7	Hup1	ENSG00000009709	Paired box 7	P23759	1	18630846-18748866	Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors	Myogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding	Cancer-related genes, Disease variant, Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	21	brain: 4.2;skeletal muscle: 5.7;tongue: 4.4	Cell type enriched	Detected in some	8	Skeletal myocytes: 11.9	Group enriched	Detected in some	6	breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	10	Bone cancer: 55.9		Region enriched	Detected in single	17	midbrain: 4.6	Region enhanced	Detected in some		thalamus: 4.3												Cluster 80: Striated muscle - Unknown function	Cluster 14: Bone cancer - Transcription	Cluster 11: Non-specific - Transcription				unprognostic (8.41e-4)	unprognostic (2.07e-1)			unprognostic (5.35e-2)	unprognostic (3.96e-2)		unprognostic (4.21e-1)						unprognostic (1.96e-1)	unprognostic (1.34e-1)			Skeletal myocytes
CACNB1	CACNLB1	ENSG00000067191	Calcium voltage-gated channel auxiliary subunit beta 1	Q02641	17	39173453-39197703	FDA approved drug targets, Predicted intracellular proteins	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	skeletal muscle: 328.8;tongue: 216.0	Cell type enriched	Detected in many	7	Skeletal myocytes: 153.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low immune cell specificity	Detected in single			Low lineage specificity	Detected in single			Low cancer specificity	Detected in all			Adipose subcutaneous - Adipose progenitor cells, Lung - Alveolar cells type 2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA023343	Approved									Cluster 16: MAIT-cells - Unknown function	Cluster 13: Striated muscle - Muscle contraction	Cluster 65: Breast cancer - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction			HPA023343: AB_1845866	unprognostic (3.44e-2)	unprognostic (1.89e-2)	unprognostic (1.69e-3)	prognostic unfavorable (3.80e-4)	unprognostic (3.99e-2)	unprognostic (1.52e-2)	unprognostic (1.37e-2)	unprognostic (2.80e-3)	unprognostic (4.43e-1)	unprognostic (1.04e-3)	unprognostic (5.98e-2)	unprognostic (3.38e-1)	unprognostic (1.94e-11)	unprognostic (7.62e-2)	unprognostic (2.30e-1)	unprognostic (1.34e-2)	unprognostic (7.44e-3)	Skeletal myocytes
PYGM	GSD5	ENSG00000068976	Glycogen phosphorylase, muscle associated	P11217	11	64746389-64759974	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Carbohydrate metabolism, Glycogen metabolism	Allosteric enzyme, Glycosyltransferase, Transferase	Disease variant, Glycogen storage disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	65	skeletal muscle: 8468.3;tongue: 3594.2	Cell type enriched	Detected in many	10	Skeletal myocytes: 538.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Immune cell enriched	Detected in some	6	basophil: 8.1	Lineage enriched	Detected in many	6	granulocytes: 8.1	Cancer enriched	Detected in some	10	Rhabdoid: 23.9	Colon - Smooth muscle cells, Heart muscle - Cardiomyocytes, Kidney - Fibroblasts, Prostate - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA056003	Enhanced								10000000	Cluster 10: Basophils - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 27: Skeletal myocytes - Muscle contraction			HPA056003: AB_2683006	unprognostic (3.33e-1)	unprognostic (6.03e-3)	unprognostic (3.87e-4)	unprognostic (1.95e-3)	unprognostic (8.71e-2)	unprognostic (1.09e-2)	unprognostic (1.25e-3)	unprognostic (2.92e-1)	unprognostic (3.88e-1)	unprognostic (3.08e-2)	unprognostic (1.12e-1)	unprognostic (2.64e-1)	unprognostic (6.33e-6)	unprognostic (3.37e-3)	unprognostic (1.81e-1)	unprognostic (1.62e-2)	unprognostic (5.68e-2)	Skeletal myocytes
CACNA1S	CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5	ENSG00000081248	Calcium voltage-gated channel subunit alpha1 S	Q13698	1	201039512-201112451	Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	86	skeletal muscle: 254.9;tongue: 193.2	Cell type enriched	Detected in some	15	Skeletal myocytes: 107.9	Cancer enhanced	Detected in single		head and neck cancer: 0.9	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		breast cancer: 1.2	Adipose visceral - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Testis - Late spermatids	Region enhanced	Detected in single		olfactory bulb: 1.8	Region enriched	Detected in single	8	olfactory bulb: 2.6	CAB009507, HPA048892, HPA056815	Enhanced										Cluster 13: Striated muscle - Muscle contraction	Cluster 2: DU4475 - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction			CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242	unprognostic (2.14e-2)		unprognostic (1.38e-1)	unprognostic (1.12e-2)	unprognostic (1.09e-1)	unprognostic (3.52e-3)	unprognostic (4.53e-2)	unprognostic (2.84e-1)		unprognostic (2.23e-1)	unprognostic (2.53e-2)	unprognostic (1.51e-1)	unprognostic (4.72e-3)	unprognostic (1.12e-1)	unprognostic (5.28e-2)	unprognostic (7.36e-2)	unprognostic (1.57e-1)	Skeletal myocytes
MYBPC2	fsMyBP-C, MGC163408, MYBPCF	ENSG00000086967	Myosin binding protein C2	Q14324	19	50432892-50466321	Predicted intracellular proteins	Cell adhesion	Actin-binding, Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	13	skeletal muscle: 4338.8;tongue: 1199.2	Cell type enriched	Detected in some	396	Skeletal myocytes: 650.3	Cancer enriched	Detected in some	9	head and neck cancer: 9.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	16	lymphoma: 28.5;Myeloma: 38.1	Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA042991	Enhanced								420000	Cluster 37: B-cells - Transcription	Cluster 33: Striated muscle - Muscle contraction	Cluster 44: Myeloma - Humoral immune response	Cluster 27: Skeletal myocytes - Muscle contraction			HPA042991: AB_2678257	unprognostic (6.48e-3)	unprognostic (2.65e-3)	unprognostic (6.25e-2)	unprognostic (3.26e-3)	unprognostic (1.91e-3)	unprognostic (2.15e-2)	unprognostic (6.22e-3)	unprognostic (2.46e-1)	unprognostic (5.38e-2)	unprognostic (9.65e-2)	unprognostic (1.05e-1)	unprognostic (1.30e-1)	unprognostic (2.19e-8)	unprognostic (1.85e-1)	unprognostic (5.74e-2)	unprognostic (2.73e-3)	unprognostic (2.73e-1)	Skeletal myocytes
MYLK2	KMLC, MLCK2, skMLCK	ENSG00000101306	Myosin light chain kinase 2	Q9H1R3	20	31819308-31834689	Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase	Cardiomyopathy, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	skeletal muscle: 732.0	Cell type enriched	Detected in some	27	Skeletal myocytes: 74.2	Cancer enhanced	Detected in some		glioma: 1.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some				Not detected	Not detected			Low region specificity	Detected in all			HPA059704, HPA059890	Enhanced		Supported	Endoplasmic reticulum							Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Endoplasmic reticulum		HPA059704: AB_2684108, HPA059890: AB_2684153	unprognostic (1.74e-2)	unprognostic (1.87e-1)	unprognostic (8.84e-2)	unprognostic (5.27e-2)	prognostic favorable (4.00e-4)	unprognostic (5.58e-2)	unprognostic (1.38e-7)	unprognostic (2.29e-1)	unprognostic (2.60e-3)	unprognostic (1.99e-1)	unprognostic (1.20e-1)	unprognostic (4.73e-2)	unprognostic (7.25e-11)	unprognostic (2.01e-1)	unprognostic (3.15e-1)	unprognostic (2.60e-2)	unprognostic (2.70e-2)	Skeletal myocytes
TNNC2	CFAP85, FAP85	ENSG00000101470	Troponin C2, fast skeletal type	P02585	20	45823214-45833745	Predicted intracellular proteins		Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	109	skeletal muscle: 30416.4;tongue: 8088.6	Cell type enriched	Detected in many	51	Skeletal myocytes: 17198.7	Cancer enhanced	Detected in many		colorectal cancer: 20.2;head and neck cancer: 22.3	Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Cancer enriched	Detected in many	4	Sarcoma: 22.3	Skeletal muscle - Skeletal myocytes	Region enriched	Detected in some	5	olfactory bulb: 6.1	Low region specificity	Detected in some			HPA043174, HPA058481	Enhanced		Approved	Nucleoplasm,Vesicles		No			560000	Cluster 19: B-cells - Humoral immune response	Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm	Vesicles	HPA043174: AB_10806380, HPA058481: AB_2683729	unprognostic (1.13e-1)	unprognostic (7.25e-2)	unprognostic (3.43e-1)	unprognostic (1.27e-1)	unprognostic (3.21e-5)	unprognostic (1.80e-2)	unprognostic (5.72e-3)	unprognostic (3.12e-3)	unprognostic (2.19e-1)	unprognostic (2.06e-1)	unprognostic (2.38e-1)	unprognostic (1.05e-1)	unprognostic (9.03e-3)	unprognostic (7.15e-3)	unprognostic (4.79e-1)	unprognostic (5.23e-2)	unprognostic (1.13e-1)	Skeletal myocytes
ATP1B4		ENSG00000101892	ATPase Na+/K+ transporting family member beta 4	Q9UN42	X	120362085-120383249	Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	28	skeletal muscle: 55.7;tongue: 21.6	Cell type enriched	Detected in some	44	Skeletal myocytes: 72.3	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Not detected	Not detected														Cluster 33: Striated muscle - Muscle contraction		Cluster 27: Skeletal myocytes - Muscle contraction								unprognostic (2.59e-2)	unprognostic (6.02e-4)						unprognostic (5.78e-1)		unprognostic (5.29e-2)				Skeletal myocytes
KCNA7	HAK6, Kv1.7	ENSG00000104848	Potassium voltage-gated channel subfamily A member 7	Q96RP8	19	49067418-49072941	FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	FDA approved drug targets	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Group enriched	Detected in some	51	skeletal muscle: 75.7;tongue: 19.5	Cell type enriched	Detected in some	33	Skeletal myocytes: 58.4	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Not detected	Not detected			Not detected	Not detected			HPA075990			Approved	Vesicles,Plasma membrane						Cluster 11: Basophils - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 3: HUVEC & TIME - Signal transduction	Cluster 27: Skeletal myocytes - Muscle contraction	Vesicles, Plasma membrane		HPA075990: 	unprognostic (2.00e-1)	unprognostic (2.10e-2)		unprognostic (1.19e-1)	unprognostic (2.72e-1)	unprognostic (1.68e-1)		unprognostic (4.31e-2)	unprognostic (3.17e-2)	unprognostic (6.97e-2)	unprognostic (2.94e-2)	unprognostic (1.26e-1)	unprognostic (2.21e-8)	unprognostic (1.70e-1)	unprognostic (2.62e-1)	unprognostic (5.80e-2)	unprognostic (5.29e-2)	Skeletal myocytes
TNNT1	ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS	ENSG00000105048	Troponin T1, slow skeletal type	P13805	19	55132698-55149206	Disease related genes, Human disease related genes, Predicted intracellular proteins		Muscle protein	Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	29	skeletal muscle: 21567.3;tongue: 13372.6	Cell type enriched	Detected in many	29	Skeletal myocytes: 1851.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enriched	Detected in many	5	eosinophil: 211.5	Lineage enriched	Detected in many	5	granulocytes: 211.5	Cancer enhanced	Detected in all		Sarcoma: 353.5	Skeletal muscle - Skeletal myocytes, Skin - Keratinocyte (other)	Region enriched	Detected in many	5	thalamus: 125.0	Region enhanced	Detected in all		thalamus: 23.1	CAB015168, HPA058448	Enhanced		Approved	Nucleoplasm,Golgi apparatus,Cytosol					79000	Cluster 45: Eosinophils - Innate immune response	Cluster 13: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm, Golgi apparatus, Cytosol		CAB015168: AB_2206426, HPA058448: AB_2683720	unprognostic (1.88e-1)	unprognostic (7.23e-2)	prognostic unfavorable (4.66e-4)	prognostic unfavorable (4.66e-4)	unprognostic (3.47e-3)	unprognostic (3.92e-3)	unprognostic (1.35e-3)	unprognostic (1.03e-3)	unprognostic (2.46e-1)	unprognostic (1.95e-1)	prognostic unfavorable (2.53e-4)	unprognostic (3.23e-1)	prognostic unfavorable (0.00e+0)	unprognostic (4.91e-2)	unprognostic (4.01e-2)	unprognostic (4.58e-2)	unprognostic (2.14e-2)	Skeletal myocytes
PITX3	ASMD	ENSG00000107859	Paired like homeodomain 3	O75364	10	102230186-102241512	Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Cataract, Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	brain: 5.5;skeletal muscle: 16.5;tongue: 6.0	Cell type enriched	Detected in some	4	Skeletal myocytes: 20.8	Not detected	Not detected			Region enriched	Detected in single	14	midbrain: 5.5	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	13	Sarcoma: 11.4	Breast - Adipocytes (Breast), Testis - Late spermatids	Not detected	Not detected			Region enhanced	Detected in some		midbrain: 9.1												Cluster 80: Striated muscle - Unknown function	Cluster 42: Sarcoma - Muscle contraction	Cluster 11: Non-specific - Transcription				unprognostic (8.13e-2)	unprognostic (4.07e-1)		unprognostic (5.15e-3)	unprognostic (6.30e-2)	unprognostic (1.06e-1)		unprognostic (6.04e-5)	unprognostic (6.30e-3)	unprognostic (2.02e-1)	unprognostic (6.36e-2)		unprognostic (2.67e-2)	unprognostic (3.73e-2)	unprognostic (1.76e-2)	unprognostic (6.76e-3)	unprognostic (4.13e-2)	Skeletal myocytes
CACNG1	CACNLG	ENSG00000108878	Calcium voltage-gated channel auxiliary subunit gamma 1	Q06432	17	67044554-67056797	FDA approved drug targets, Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	55	skeletal muscle: 327.7;tongue: 121.8	Cell type enriched	Detected in single	323	Skeletal myocytes: 141.5	Cancer enhanced	Detected in some		breast cancer: 1.6;head and neck cancer: 1.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Breast - Breast glandular cells	Region enriched	Detected in single	6	basal ganglia: 3.4	Not detected	Not detected														Cluster 33: Striated muscle - Muscle contraction	Cluster 65: Breast cancer - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction				unprognostic (1.76e-1)	unprognostic (9.83e-3)		unprognostic (1.75e-5)	unprognostic (2.60e-1)	unprognostic (6.72e-3)	unprognostic (2.85e-1)	unprognostic (1.44e-2)		unprognostic (4.84e-3)	unprognostic (1.07e-1)	unprognostic (4.20e-2)		unprognostic (1.60e-1)	unprognostic (2.31e-1)	unprognostic (3.03e-1)	unprognostic (1.94e-1)	Skeletal myocytes
MYH1	MGC133384, MYHa, MyHC-2X/D, MYHSA1	ENSG00000109061	Myosin heavy chain 1	P12882	17	10492307-10518542	Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	137	skeletal muscle: 7882.0	Cell type enriched	Detected in some	94	Skeletal myocytes: 776.9	Cancer enriched	Detected in single	45	head and neck cancer: 8.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Skeletal muscle - Skeletal myocytes, Testis - Early spermatids	Not detected	Not detected							HPA001349, CAB010759	Enhanced		Uncertain	Focal adhesion sites					98000000		Cluster 33: Striated muscle - Muscle contraction	Cluster 20: Connective tissue cells - ECM organization	Cluster 27: Skeletal myocytes - Muscle contraction	Focal adhesion sites		CAB010759: AB_477248, HPA001349: AB_1079437	unprognostic (2.87e-2)					unprognostic (3.27e-3)		unprognostic (1.91e-1)	unprognostic (8.95e-3)	unprognostic (4.49e-2)	unprognostic (7.31e-2)		unprognostic (5.63e-3)	unprognostic (9.85e-4)	unprognostic (1.92e-1)		unprognostic (4.58e-2)	Skeletal myocytes
MYF6	bHLHc4, MRF4	ENSG00000111046	Myogenic factor 6	P23409	12	80707634-80709474	Human disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Myogenesis	Developmental protein, DNA-binding	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Group enriched	Detected in some	42	skeletal muscle: 440.0;tongue: 207.6	Cell type enriched	Detected in some	203	Skeletal myocytes: 754.2	Cancer enriched	Detected in some	5	head and neck cancer: 3.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		Sarcoma: 1.9		Not detected	Not detected			Not detected	Not detected			HPA065102			Supported	Nucleoplasm,Mitotic spindle,Cytosol		Yes					Cluster 33: Striated muscle - Muscle contraction	Cluster 34: Rabdoid cancer - Embryonic development	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm	Mitotic spindle, Cytosol	HPA065102: 					unprognostic (2.20e-2)	prognostic unfavorable (2.05e-4)		unprognostic (9.88e-2)							unprognostic (6.64e-1)			Skeletal myocytes
PRKAG3		ENSG00000115592	Protein kinase AMP-activated non-catalytic subunit gamma 3	Q9UGI9	2	218822383-218832086	FDA approved drug targets, Predicted intracellular proteins	Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism		FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	30	skeletal muscle: 70.4;tongue: 17.9	Cell type enriched	Detected in some	27	Skeletal myocytes: 28.7	Not detected	Not detected			Region enhanced	Detected in single		basal ganglia: 1.4	Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Not detected	Not detected			Low region specificity	Detected in some														Cluster 33: Striated muscle - Muscle contraction	Cluster 44: Myeloma - Humoral immune response	Cluster 27: Skeletal myocytes - Muscle contraction				unprognostic (3.51e-1)	unprognostic (4.41e-3)		unprognostic (2.05e-1)	unprognostic (1.53e-1)	unprognostic (2.47e-2)	unprognostic (1.80e-1)	unprognostic (1.86e-3)	unprognostic (7.74e-2)	unprognostic (3.44e-2)	unprognostic (5.85e-2)	unprognostic (3.27e-1)	unprognostic (9.04e-2)	unprognostic (9.95e-2)	unprognostic (1.49e-1)	unprognostic (2.97e-1)	unprognostic (7.69e-2)	Skeletal myocytes
AMPD1	MAD, MADA	ENSG00000116748	Adenosine monophosphate deaminase 1	P23109	1	114673090-114695618	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins	Nucleotide metabolism	Hydrolase	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	23	skeletal muscle: 559.2;tongue: 211.4	Cell type enriched	Detected in some	4	Skeletal myocytes: 157.4	Cancer enhanced	Detected in single		head and neck cancer: 0.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	18	Myeloma: 63.1	Breast - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Skeletal myocytes, Stomach - Plasma cells, Thyroid - Plasma cells	Not detected	Not detected			Not detected	Not detected			HPA026478, HPA028080	Enhanced				Intracellular and membrane				38000	Cluster 37: B-cells - Transcription	Cluster 33: Striated muscle - Muscle contraction	Cluster 44: Myeloma - Humoral immune response	Cluster 45: Plasma cells - Humoral immune response			HPA026478: AB_10599969, HPA028080: AB_10600776	unprognostic (1.98e-3)	unprognostic (1.43e-3)	unprognostic (8.75e-3)	unprognostic (8.03e-2)		unprognostic (1.95e-2)		unprognostic (5.61e-3)	unprognostic (8.21e-2)	unprognostic (4.29e-3)	unprognostic (2.48e-1)	unprognostic (2.26e-1)	unprognostic (1.36e-5)	unprognostic (1.68e-1)	unprognostic (3.70e-1)	unprognostic (3.36e-1)	unprognostic (4.02e-1)	Skeletal myocytes
MYOT	LGMD1, LGMD1A, TTID	ENSG00000120729	Myotilin	Q9UBF9	5	137867858-137887851	Disease related genes, Human disease related genes, Predicted intracellular proteins		Actin-binding, Muscle protein	Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	61	skeletal muscle: 2183.8;tongue: 2038.6	Cell type enriched	Detected in some	5	Skeletal myocytes: 412.7	Cancer enhanced	Detected in some		head and neck cancer: 3.7	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	7	Sarcoma: 13.8	Colon - Enteric glia cells, Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Not detected	Not detected			HPA037733, HPA037734	Enhanced								9100		Cluster 13: Striated muscle - Muscle contraction	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 27: Skeletal myocytes - Muscle contraction			HPA037733: AB_10697082, HPA037734: AB_2675638	unprognostic (5.85e-2)	unprognostic (2.38e-2)	unprognostic (6.93e-2)	unprognostic (3.08e-1)	unprognostic (1.27e-1)	prognostic unfavorable (8.85e-4)	unprognostic (8.03e-2)	unprognostic (1.17e-2)	unprognostic (1.54e-2)	unprognostic (2.02e-2)	unprognostic (6.44e-2)	unprognostic (1.14e-1)	unprognostic (7.56e-4)	unprognostic (1.72e-2)	unprognostic (2.42e-1)	unprognostic (2.10e-1)	unprognostic (1.40e-1)	Skeletal myocytes
MYOG	bHLHc3, MYF4	ENSG00000122180	Myogenin	P15173	1	203083129-203086012	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	18	skeletal muscle: 101.0;tongue: 46.7	Cell type enriched	Detected in single	463	Skeletal myocytes: 77.2	Group enriched	Detected in some	6	head and neck cancer: 3.9;testis cancer: 1.7	Region enriched	Detected in single	5	cerebellum: 2.5	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	89	Sarcoma: 45.1		Not detected	Not detected			Low region specificity	Detected in some			HPA028336			Supported	Nucleoplasm							Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm		HPA028336: AB_2672562	unprognostic (1.71e-1)				unprognostic (1.64e-1)	unprognostic (1.05e-3)				unprognostic (2.22e-1)			unprognostic (2.79e-9)	unprognostic (3.96e-1)	unprognostic (2.56e-1)			Skeletal myocytes
MYH2	IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2	ENSG00000125414	Myosin heavy chain 2	Q9UKX2	17	10521148-10549700	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	84	skeletal muscle: 12790.2;tongue: 6140.2	Cell type enriched	Detected in some	1048	Skeletal myocytes: 1464.8	Cancer enriched	Detected in single	60	head and neck cancer: 27.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	Rhabdoid: 2.1;testis cancer: 1.7	Skeletal muscle - Skeletal myocytes									HPA001349, CAB010760	Enhanced		Uncertain	Focal adhesion sites					81000000		Cluster 33: Striated muscle - Muscle contraction	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 27: Skeletal myocytes - Muscle contraction	Focal adhesion sites		CAB010760: AB_477190, HPA001349: AB_1079437	unprognostic (6.50e-2)					unprognostic (1.86e-2)		unprognostic (4.76e-2)	unprognostic (1.92e-2)	unprognostic (1.05e-4)	unprognostic (2.89e-1)	unprognostic (9.51e-2)	unprognostic (2.03e-2)	unprognostic (1.09e-2)	unprognostic (4.30e-2)			Skeletal myocytes
MYOD1	bHLHc1, MYF3, MYOD, PUM	ENSG00000129152	Myogenic differentiation 1	P15172	11	17719571-17722136	Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Myogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Cancer-related genes, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	skeletal muscle: 36.1	Cell type enriched	Detected in some	21	Skeletal myocytes: 77.2	Cancer enhanced	Detected in single		ovarian cancer: 0.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	259	Sarcoma: 74.1		Not detected	Not detected			Low region specificity	Detected in many			HPA055436, HPA078647			Enhanced	Nucleoplasm							Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm		HPA055436: , HPA078647: 						unprognostic (1.07e-3)				unprognostic (2.10e-1)					unprognostic (1.01e-1)			Skeletal myocytes
CDH15	CDH14, CDH3	ENSG00000129910	Cadherin 15	P55291	16	89171748-89195492	Disease related genes, Human disease related genes, Predicted membrane proteins	Cell adhesion		Disease variant, Intellectual disability	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	brain: 24.4;skeletal muscle: 57.0	Cell type enriched	Detected in some	5	Skeletal myocytes: 67.3	Low cancer specificity	Detected in some			Region enriched	Detected in some	15	cerebellum: 24.4	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	24	Sarcoma: 32.2		Region enriched	Detected in many	7	cerebellum: 15.7	Region enriched	Detected in some	17	cerebellum: 18.7	HPA009139, HPA070961	Enhanced	Supported	Enhanced	Golgi apparatus,Plasma membrane					870000		Cluster 80: Striated muscle - Unknown function	Cluster 42: Sarcoma - Muscle contraction	Cluster 11: Non-specific - Transcription	Golgi apparatus, Plasma membrane		HPA009139: AB_1078372, HPA070961: AB_2686328	unprognostic (1.26e-1)	unprognostic (7.70e-3)	unprognostic (6.64e-3)	unprognostic (2.81e-1)	unprognostic (7.79e-3)	unprognostic (2.70e-3)	unprognostic (2.84e-3)	unprognostic (4.37e-2)	unprognostic (2.30e-3)	unprognostic (7.66e-2)	unprognostic (4.05e-2)	unprognostic (1.73e-1)	unprognostic (1.14e-7)	unprognostic (3.09e-2)	unprognostic (3.13e-1)	unprognostic (5.50e-2)	unprognostic (2.64e-2)	Skeletal myocytes
TNNT3	AMCD2B, DA2B, DKFZp779M2348, FSSV	ENSG00000130595	Troponin T3, fast skeletal type	P45378	11	1919703-1938706	Disease related genes, Human disease related genes, Predicted intracellular proteins		Muscle protein	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Group enriched	Detected in many	43	skeletal muscle: 13906.8;tongue: 4507.7	Cell type enriched	Detected in many	67	Skeletal myocytes: 7524.0	Group enriched	Detected in many	9	head and neck cancer: 28.8;urothelial cancer: 19.0	Not detected	Not detected			Immune cell enriched	Detected in single	17	basophil: 5.3	Lineage enriched	Detected in single	17	granulocytes: 5.3	Cancer enhanced	Detected in some		Bladder cancer: 16.2;Rhabdoid: 15.9	Skeletal muscle - Skeletal myocytes, Stomach - Fibroblasts, Thyroid - Fibroblasts	Region enhanced	Detected in some		olfactory bulb: 5.1	Low region specificity	Detected in single			CAB002451, HPA037810, HPA056909	Enhanced								470000	Cluster 34: Basophils - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 60: Keratinocytes - Epithelial cell function	Cluster 27: Skeletal myocytes - Muscle contraction			CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273	unprognostic (1.01e-2)	prognostic favorable (7.37e-4)	unprognostic (2.17e-2)	unprognostic (2.30e-3)	unprognostic (1.23e-2)	unprognostic (1.29e-2)	unprognostic (4.53e-3)	unprognostic (1.20e-1)	unprognostic (5.88e-2)	unprognostic (4.29e-3)	unprognostic (3.53e-2)	unprognostic (4.34e-1)	unprognostic (1.42e-5)	unprognostic (2.99e-2)	unprognostic (1.61e-1)	unprognostic (1.79e-2)	unprognostic (2.90e-2)	Skeletal myocytes
TNNI2	AMCD2B, DA2B, FSSV	ENSG00000130598	Troponin I2, fast skeletal type	P48788	11	1838981-1841680	Disease related genes, Human disease related genes, Predicted intracellular proteins		Actin-binding, Muscle protein	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	25	skeletal muscle: 7969.8;tongue: 2622.3	Cell type enriched	Detected in many	16	Skeletal myocytes: 9387.7	Group enriched	Detected in many	10	cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8	Not detected	Not detected			Immune cell enhanced	Detected in many		plasmacytoid DC: 86.4	Low lineage specificity	Detected in many			Cancer enhanced	Detected in many		Bladder cancer: 7.9	Skeletal muscle - Skeletal myocytes	Region enriched	Detected in single	6	olfactory bulb: 5.1	Not detected	Not detected			CAB018697, HPA055938	Enhanced		Approved	Plasma membrane,Intermediate filaments					110000	Cluster 52: Eosinophils - Transcription	Cluster 33: Striated muscle - Muscle contraction	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction	Plasma membrane	Intermediate filaments	CAB018697: AB_628400, HPA055938: AB_2682976	unprognostic (2.03e-2)	unprognostic (1.13e-1)	unprognostic (1.29e-2)	unprognostic (3.70e-1)	unprognostic (1.85e-1)	unprognostic (1.02e-2)	unprognostic (9.99e-3)	unprognostic (1.01e-1)	unprognostic (1.73e-1)	unprognostic (1.51e-1)	unprognostic (1.10e-1)	unprognostic (2.70e-1)	unprognostic (1.23e-3)	unprognostic (5.92e-3)	unprognostic (5.62e-2)	unprognostic (1.77e-1)	unprognostic (2.79e-2)	Skeletal myocytes
FBP2		ENSG00000130957	Fructose-bisphosphatase 2	O00757	9	94558720-94593824	Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins	Carbohydrate metabolism, Gluconeogenesis	Allosteric enzyme, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	8	skeletal muscle: 753.6;tongue: 385.3	Cell type enriched	Detected in some	9	Skeletal myocytes: 93.0	Cancer enhanced	Detected in some		stomach cancer: 1.2	Region enriched	Detected in some	4	hippocampal formation: 6.1	Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes, Skin - Sebaceous gland cells	Not detected	Not detected			Not detected	Not detected			HPA012513, HPA077371	Enhanced		Approved	Plasma membrane,Cytosol					960000		Cluster 13: Striated muscle - Muscle contraction	Cluster 23: B-cell cancers - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction	Plasma membrane, Cytosol		HPA012513: AB_1848446, HPA077371: 	unprognostic (3.88e-2)	unprognostic (3.54e-4)	unprognostic (2.38e-1)	unprognostic (6.03e-2)		unprognostic (2.21e-1)	unprognostic (1.54e-2)	unprognostic (9.40e-4)	unprognostic (3.95e-3)	unprognostic (5.11e-2)	unprognostic (2.39e-2)	unprognostic (4.69e-2)	unprognostic (2.53e-1)	unprognostic (1.36e-2)	unprognostic (2.03e-1)		unprognostic (1.48e-4)	Skeletal myocytes
EDA2R	EDA-A2R, EDAA2R, TNFRSF27, XEDAR	ENSG00000131080	Ectodysplasin A2 receptor	Q9HAV5	X	66595637-66639298	Predicted membrane proteins	Differentiation	Developmental protein, Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	6	Skeletal myocytes: 48.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		testis cancer: 25.2	Adipose subcutaneous - Adipose progenitor cells, Skeletal muscle - Fibroblasts	Not detected	Not detected							HPA054522			Approved	Cell Junctions							Cluster 89: Fibroblasts - ECM organization	Cluster 68: Kidney - Mixed function	Cluster 27: Skeletal myocytes - Muscle contraction	Cell Junctions		HPA054522: AB_2682516	unprognostic (1.31e-3)	unprognostic (3.17e-3)	unprognostic (2.19e-1)	unprognostic (8.49e-3)	unprognostic (4.15e-3)	unprognostic (3.63e-3)	unprognostic (2.48e-2)	unprognostic (3.37e-2)	unprognostic (2.82e-1)	unprognostic (7.17e-2)	unprognostic (6.04e-2)	unprognostic (2.74e-1)	unprognostic (1.01e-1)	unprognostic (2.12e-2)	unprognostic (8.23e-2)	unprognostic (4.92e-2)	unprognostic (3.08e-1)	Skeletal myocytes
MYH8	MyHC-peri, MyHC-pn	ENSG00000133020	Myosin heavy chain 8	P13535	17	10390322-10421950	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Group enriched	Detected in some	9	esophagus: 15.9;lymphoid tissue: 10.7;skeletal muscle: 16.7;tongue: 10.0	Cell type enriched	Detected in some	15	Skeletal myocytes: 1332.2	Cancer enhanced	Detected in some		head and neck cancer: 0.7;renal cancer: 0.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	15	Rhabdoid: 9.8	Kidney - Ascending Loop of Henle cells, Testis - Spermatogonia	Not detected	Not detected			Not detected	Not detected			HPA001349, CAB016527	Enhanced		Uncertain	Focal adhesion sites					53000000		Cluster 59: Non-specific - Translation	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 27: Skeletal myocytes - Muscle contraction	Focal adhesion sites		CAB016527: AB_2147291, HPA001349: AB_1079437	unprognostic (5.87e-2)					unprognostic (5.13e-3)		unprognostic (4.12e-2)	unprognostic (1.25e-2)		unprognostic (2.29e-3)	unprognostic (1.08e-1)	unprognostic (5.02e-3)	unprognostic (7.87e-2)	unprognostic (1.61e-1)		unprognostic (3.56e-1)	Skeletal myocytes
MYBPH		ENSG00000133055	Myosin binding protein H	Q13203	1	203167811-203175826	Predicted intracellular proteins	Cell adhesion	Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		salivary gland: 16.2;skeletal muscle: 74.2;tongue: 19.6	Cell type enriched	Detected in single	33	Skeletal myocytes: 30.7	Cancer enriched	Detected in many	4	head and neck cancer: 20.2	Low region specificity	Detected in many			Immune cell enriched	Detected in single	5	plasmacytoid DC: 2.5	Lineage enriched	Detected in single	5	dendritic cells: 2.5	Group enriched	Detected in some	4	Leukemia: 22.5;lymphoma: 6.7;Sarcoma: 15.1		Not detected	Not detected			Low region specificity	Detected in many			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria					9700	Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 66: Myeloid cells - Innate immune response	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm, Nucleoli, Mitochondria		HPA061383: AB_2684497	unprognostic (2.26e-4)	unprognostic (2.04e-1)	unprognostic (3.50e-1)	unprognostic (1.06e-1)	unprognostic (3.82e-2)	unprognostic (1.32e-3)	unprognostic (3.42e-1)	unprognostic (6.84e-2)	unprognostic (1.18e-1)	unprognostic (2.96e-1)	unprognostic (2.86e-1)	unprognostic (1.75e-1)	unprognostic (7.62e-4)	unprognostic (1.51e-1)	unprognostic (3.34e-2)	unprognostic (1.14e-1)	unprognostic (1.74e-1)	Skeletal myocytes
CHRND	ACHRD	ENSG00000135902	Cholinergic receptor nicotinic delta subunit	Q07001	2	232525993-232536667	Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Congenital myasthenic syndrome, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	skeletal muscle: 57.6	Cell type enriched	Detected in some	10	Skeletal myocytes: 33.7	Cancer enriched	Detected in single	7	head and neck cancer: 1.5	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	87	Sarcoma: 27.2		Not detected	Not detected			Not detected	Not detected			HPA056404, HPA065404			Supported	Nucleoplasm,Plasma membrane,Cytosol							Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Plasma membrane	Nucleoplasm, Cytosol	HPA056404: AB_2732603, HPA065404: AB_2732734				unprognostic (1.69e-2)	unprognostic (7.93e-2)	unprognostic (3.28e-3)	unprognostic (7.75e-3)	unprognostic (6.04e-2)	unprognostic (1.10e-1)	unprognostic (7.25e-2)	unprognostic (1.90e-1)		unprognostic (4.97e-8)	unprognostic (7.52e-2)	unprognostic (2.86e-1)	unprognostic (2.46e-1)		Skeletal myocytes
LBX1	HPX6, LBX1H	ENSG00000138136	Ladybird homeobox 1	P52954	10	101226195-101229794	Predicted intracellular proteins, Transcription factors	Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	skeletal muscle: 26.5	Cell type enriched	Detected in single	17	Skeletal myocytes: 3.0	Not detected	Not detected			Group enriched	Detected in many	5	cerebellum: 1.9;medulla oblongata: 3.5;pons: 2.5;spinal cord: 4.5	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Bone cancer: 4.9		Group enriched	Detected in some	24	cerebellum: 1.6;pons and medulla: 3.0	Group enriched	Detected in some	18	cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0	HPA002016, HPA002086, CAB079927	Uncertain		Approved	Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol							Cluster 80: Striated muscle - Unknown function	Cluster 28: Bone cancer CADO-ES1 - Glutamate signalling	Cluster 11: Non-specific - Transcription	Nucleoplasm	Nucleoli, Nuclear bodies, Cytosol	CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242		unprognostic (4.13e-1)			unprognostic (3.86e-2)	unprognostic (2.25e-2)		unprognostic (2.29e-1)	unprognostic (7.28e-3)	unprognostic (3.31e-1)				unprognostic (9.76e-2)	unprognostic (1.45e-1)			Skeletal myocytes
CHRNA1	CHRNA	ENSG00000138435	Cholinergic receptor nicotinic alpha 1 subunit	P02708	2	174747592-174787935	Disease related genes, Human disease related genes, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Congenital myasthenic syndrome, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	skeletal muscle: 170.1	Cell type enriched	Detected in some	13	Skeletal myocytes: 152.4	Cancer enhanced	Detected in many		glioma: 5.8	Group enriched	Detected in some	13	cerebral cortex: 12.8;hippocampal formation: 5.5	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	39	Sarcoma: 113.1	Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in many			HPA071554	Enhanced		Supported	Plasma membrane						Cluster 47: Plasmacytoid DCs - Protein folding	Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 11: Non-specific - Transcription	Plasma membrane		HPA071554: AB_2686416	unprognostic (1.49e-1)	unprognostic (1.97e-1)	unprognostic (1.22e-3)	unprognostic (2.28e-2)	unprognostic (2.96e-1)	unprognostic (8.55e-3)	unprognostic (5.34e-2)	unprognostic (5.29e-3)	unprognostic (9.59e-2)	unprognostic (9.64e-2)	unprognostic (9.66e-2)	unprognostic (6.37e-2)	unprognostic (4.18e-4)	unprognostic (2.04e-1)	unprognostic (1.31e-1)	unprognostic (1.86e-1)	unprognostic (7.18e-2)	Skeletal myocytes
FEM1A		ENSG00000141965	Fem-1 homolog A	Q9BSK4	19	4791734-4801273	Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	11	skeletal muscle: 273.6;tongue: 121.2	Cell type enriched	Detected in all	4	Skeletal myocytes: 119.8	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Heart muscle - Cardiomyocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016565, HPA063622			Supported	Nucleoplasm,Golgi apparatus,Cytosol						Cluster 34: Basophils - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 53: Non-specific - mRNA processing	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm, Golgi apparatus	Cytosol	HPA016565: AB_1848489, HPA063622: AB_2685063	unprognostic (4.62e-2)	unprognostic (1.96e-1)	unprognostic (1.66e-1)	unprognostic (6.75e-2)	unprognostic (3.60e-1)	unprognostic (2.42e-3)	unprognostic (2.04e-1)	unprognostic (6.74e-2)	unprognostic (1.25e-2)	unprognostic (9.21e-2)	unprognostic (2.28e-3)	unprognostic (6.25e-2)	unprognostic (6.18e-5)	unprognostic (3.72e-3)	unprognostic (1.25e-1)	unprognostic (1.91e-1)	unprognostic (4.70e-2)	Skeletal myocytes
SYPL2	Mg29	ENSG00000143028	Synaptophysin like 2	Q5VXT5	1	109466546-109482134	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	13	skeletal muscle: 363.5;tongue: 175.3	Cell type enriched	Detected in some	4	Skeletal myocytes: 53.4	Cancer enhanced	Detected in many		renal cancer: 3.6	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Rhabdoid: 2.7;Sarcoma: 3.3	Prostate - Smooth muscle cells, Skin - Sebaceous gland cells, Testis - Sertoli cells	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA076657			Approved	Plasma membrane,Cytosol							Cluster 33: Striated muscle - Muscle contraction	Cluster 20: Connective tissue cells - ECM organization	Cluster 27: Skeletal myocytes - Muscle contraction	Cytosol	Plasma membrane	HPA076657: 	unprognostic (1.82e-2)	unprognostic (1.81e-1)	unprognostic (2.90e-4)	unprognostic (6.63e-2)	unprognostic (1.35e-1)	unprognostic (9.36e-3)	unprognostic (2.84e-2)	unprognostic (2.57e-1)	unprognostic (2.35e-1)	unprognostic (3.11e-1)	unprognostic (2.34e-1)	unprognostic (1.08e-1)	prognostic favorable (3.05e-4)	unprognostic (2.54e-3)	unprognostic (3.40e-1)	unprognostic (9.46e-3)	unprognostic (6.39e-4)	Skeletal myocytes
CASQ1	CASQ, PDIB1	ENSG00000143318	Calsequestrin 1	P31415	1	160190575-160201886	Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters		Muscle protein	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	64	skeletal muscle: 4442.6;tongue: 1892.7	Cell type enriched	Detected in some	8	Skeletal myocytes: 197.0	Cancer enhanced	Detected in many		glioma: 5.1	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Bladder cancer: 3.1;testis cancer: 3.5	Skeletal muscle - Skeletal myocytes, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA007845, CAB015170, HPA026823	Enhanced		Approved	Nucleoplasm,Mitochondria	Intracellular and membrane				270000		Cluster 33: Striated muscle - Muscle contraction	Cluster 11: Lymphoma - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm, Mitochondria		CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557	unprognostic (1.87e-2)	unprognostic (3.97e-3)	unprognostic (1.01e-1)	unprognostic (1.13e-2)	unprognostic (2.03e-2)	unprognostic (6.85e-2)	unprognostic (1.96e-2)	unprognostic (4.65e-3)	unprognostic (3.85e-2)	unprognostic (1.01e-2)	unprognostic (2.87e-2)	unprognostic (3.01e-2)	unprognostic (3.21e-3)	unprognostic (9.04e-4)	unprognostic (1.80e-1)	unprognostic (1.58e-1)	prognostic favorable (8.93e-5)	Skeletal myocytes
SEMA6C	KIAA1869	ENSG00000143434	Semaphorin 6C	Q9H3T2	1	151131685-151146664	Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Neurogenesis	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Group enriched	Detected in all	5	skeletal muscle: 322.9;tongue: 96.9	Cell type enriched	Detected in many	4	Skeletal myocytes: 99.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes, Testis - Sertoli cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA076150, HPA077625			Approved	Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol	Intracellular and membrane				1500000		Cluster 33: Striated muscle - Muscle contraction	Cluster 23: B-cell cancers - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm, Plasma membrane	Nucleoli fibrillar center, Cytosol	HPA076150: , HPA077625: 	unprognostic (6.97e-2)	unprognostic (8.40e-2)	unprognostic (1.56e-3)	prognostic unfavorable (3.27e-4)	unprognostic (2.79e-1)	unprognostic (2.88e-2)	unprognostic (3.00e-2)	unprognostic (1.24e-2)	unprognostic (5.66e-3)	unprognostic (4.25e-2)	prognostic favorable (3.06e-5)	unprognostic (3.72e-2)	unprognostic (1.67e-2)	unprognostic (6.12e-2)	unprognostic (9.49e-2)	unprognostic (1.10e-1)	unprognostic (1.85e-1)	Skeletal myocytes
ACTA1	ACTA, NEM3	ENSG00000143632	Actin alpha 1, skeletal muscle	P68133	1	229431245-229434098	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Muscle protein	Disease variant, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	skeletal muscle: 133409.0	Cell type enriched	Detected in some	5	Skeletal myocytes: 16202.1	Group enriched	Detected in many	18	head and neck cancer: 133.1;prostate cancer: 34.7	Low region specificity	Detected in many			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Cancer enhanced	Detected in some		breast cancer: 3.7;Sarcoma: 3.0	Skeletal muscle - Skeletal myocytes, Skin - Smooth muscle cells	Low region specificity	Detected in all							CAB000045, HPA041264, HPA041271	Enhanced								2800000000	Cluster 45: Eosinophils - Innate immune response	Cluster 33: Striated muscle - Muscle contraction	Cluster 6: BEWO - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction			CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386	unprognostic (5.59e-2)	unprognostic (1.60e-2)	unprognostic (1.77e-1)	unprognostic (3.07e-4)	unprognostic (5.75e-3)	unprognostic (3.84e-3)	unprognostic (1.86e-1)	unprognostic (7.61e-2)	unprognostic (1.32e-1)	unprognostic (2.24e-1)	unprognostic (2.64e-3)	unprognostic (2.50e-1)	unprognostic (1.56e-3)	unprognostic (9.40e-4)	unprognostic (2.61e-1)	unprognostic (1.58e-2)	unprognostic (1.01e-1)	Skeletal myocytes
GADL1		ENSG00000144644	Glutamate decarboxylase like 1	Q6ZQY3	3	30726200-30894765	Enzymes, Predicted intracellular proteins		Decarboxylase, Lyase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	skeletal muscle: 25.8;tongue: 11.3	Cell type enriched	Detected in some	7	Skeletal myocytes: 16.8	Not detected	Not detected			Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Kidney - Ascending Loop of Henle cells, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA039160, HPA040229	Uncertain		Approved	Plasma membrane,Cytosol							Cluster 33: Striated muscle - Muscle contraction	Cluster 14: Bone cancer - Transcription	Cluster 27: Skeletal myocytes - Muscle contraction	Plasma membrane, Cytosol		HPA039160: AB_10796222, HPA040229: AB_10796118	unprognostic (4.96e-2)	unprognostic (1.30e-2)	unprognostic (9.83e-2)	unprognostic (1.39e-2)	unprognostic (5.60e-2)	unprognostic (7.32e-2)		unprognostic (5.05e-3)	unprognostic (8.37e-2)	unprognostic (1.23e-2)	unprognostic (2.02e-3)	unprognostic (1.63e-1)	unprognostic (1.98e-5)	unprognostic (8.81e-2)	unprognostic (4.54e-2)	unprognostic (4.39e-1)	unprognostic (1.06e-1)	Skeletal myocytes
ASB10	GLC1F	ENSG00000146926	Ankyrin repeat and SOCS box containing 10	Q8WXI3	7	151175698-151187832	Disease related genes, Human disease related genes, Predicted intracellular proteins	Ubl conjugation pathway		Disease variant, Glaucoma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 26.7;skeletal muscle: 77.9;tongue: 14.2	Cell type enriched	Detected in some	4	Skeletal myocytes: 39.6	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Not detected	Not detected			HPA079685	Enhanced										Cluster 13: Striated muscle - Muscle contraction	Cluster 17: RS4;11 - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction			HPA079685: 						unprognostic (6.72e-3)				unprognostic (1.96e-1)								Skeletal myocytes
ARHGAP36	FLJ30058	ENSG00000147256	Rho GTPase activating protein 36	Q6ZRI8	X	131058346-131089885	Predicted intracellular proteins		GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Group enriched	Detected in some	22	adrenal gland: 105.4;brain: 144.3;pituitary gland: 176.9	Cell type enriched	Detected in some	21	Skeletal myocytes: 31.7	Cancer enriched	Detected in some	21	thyroid cancer: 62.5	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	8	Neuroblastoma: 34.8	Testis - Spermatogonia	Region enhanced	Detected in many		hypothalamus: 89.4	Low region specificity	Detected in many			HPA002064, HPA076209	Enhanced		Approved	Nucleoplasm,Vesicles,Plasma membrane		Yes					Cluster 26: Pituitary gland - Hormone signaling	Cluster 21: Neuroblastoma - Neuronal signaling	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm	Vesicles, Plasma membrane	HPA002064: AB_1078891, HPA076209: 	unprognostic (2.92e-2)			unprognostic (7.71e-9)	unprognostic (2.19e-1)	unprognostic (8.15e-2)				unprognostic (1.67e-1)	unprognostic (1.78e-1)	unprognostic (2.73e-1)		unprognostic (1.40e-2)	unprognostic (1.34e-2)	unprognostic (2.31e-1)		Skeletal myocytes
IDI2	IPPI2	ENSG00000148377	Isopentenyl-diphosphate delta isomerase 2	Q9BXS1	10	1018910-1025859	Enzymes, Metabolic proteins, Predicted intracellular proteins	Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism	Isomerase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	skeletal muscle: 273.8	Cell type enriched	Detected in some	10	Skeletal myocytes: 18.8	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		skin cancer: 1.1		Not detected	Not detected							HPA041254			Supported	Vesicles							Cluster 33: Striated muscle - Muscle contraction	Cluster 16: Skin cancer - Melanocyte processes	Cluster 27: Skeletal myocytes - Muscle contraction	Vesicles		HPA041254: AB_10794270									unprognostic (6.69e-3)	unprognostic (4.05e-2)				unprognostic (1.64e-1)				Skeletal myocytes
PDLIM3	ALP	ENSG00000154553	PDZ and LIM domain 3	Q53GG5	4	185500660-185535507	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	10	skeletal muscle: 4781.7;tongue: 1519.6	Cell type enriched	Detected in many	7	Skeletal myocytes: 2366.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		Myeloma: 25.2;Sarcoma: 28.0	Adipose subcutaneous - Smooth muscle cells, Colon - Smooth muscle cells, Lung - Smooth muscle cells, Prostate - Smooth muscle cells, Skin - Smooth muscle cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA004749	Enhanced		Supported	Cytosol					240000		Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Cytosol		HPA004749: AB_1855150	unprognostic (2.75e-1)	unprognostic (3.85e-2)	unprognostic (3.20e-2)	unprognostic (2.49e-1)	unprognostic (1.08e-2)	unprognostic (1.11e-2)	prognostic unfavorable (7.22e-4)	unprognostic (3.15e-2)	unprognostic (3.64e-1)	unprognostic (1.62e-1)	unprognostic (9.46e-2)	unprognostic (3.77e-1)	prognostic unfavorable (4.97e-7)	unprognostic (1.64e-3)	unprognostic (7.77e-2)	prognostic unfavorable (2.13e-6)	unprognostic (2.78e-3)	Skeletal myocytes
MAP3K7CL	C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4	ENSG00000156265	MAP3K7 C-terminal like	P57077	21	29077471-29175889	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 41.2;tongue: 45.6	Cell type enriched	Detected in many	5	Skeletal myocytes: 173.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enhanced	Detected in all		basophil: 53.1	Group enriched	Detected in all	8	B-cells: 22.8;granulocytes: 53.1;monocytes: 14.1	Cancer enhanced	Detected in all		Sarcoma: 45.8						Not detected	Not detected			HPA030079, HPA042439	Uncertain		Approved	Nucleoplasm						Cluster 34: Basophils - Unknown function	Cluster 13: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 4: Platelets - Platelet activation	Nucleoplasm		HPA030079: AB_2673299, HPA042439: AB_10794422	unprognostic (2.23e-1)	unprognostic (2.06e-1)	unprognostic (9.36e-2)	unprognostic (1.99e-3)	unprognostic (4.98e-2)	unprognostic (7.00e-3)	unprognostic (3.40e-3)	unprognostic (1.38e-1)	unprognostic (6.22e-2)	unprognostic (1.93e-2)	unprognostic (1.28e-3)	unprognostic (4.39e-3)	prognostic unfavorable (8.31e-6)	unprognostic (2.68e-3)	unprognostic (1.57e-1)	unprognostic (1.12e-1)	unprognostic (8.10e-2)	Skeletal myocytes
KLHL40	KBTBD5, NEM8, SRYP	ENSG00000157119	Kelch like family member 40	Q2TBA0	3	42685537-42692544	Disease related genes, Human disease related genes, Predicted intracellular proteins	Ubl conjugation pathway	Developmental protein	Disease variant, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	62	skeletal muscle: 431.2;tongue: 162.3	Cell type enriched	Detected in some	25	Skeletal myocytes: 257.3	Cancer enhanced	Detected in single		head and neck cancer: 1.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Testis - Late spermatids	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA024463, HPA052201	Enhanced										Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction			HPA024463: AB_1852095, HPA052201: AB_2681759					unprognostic (1.13e-1)	unprognostic (3.28e-2)			unprognostic (1.19e-1)	unprognostic (2.09e-1)		unprognostic (7.85e-2)			unprognostic (2.50e-1)	unprognostic (4.04e-1)		Skeletal myocytes
TNNI1		ENSG00000159173	Troponin I1, slow skeletal type	P19237	1	201403768-201429866	Predicted intracellular proteins		Actin-binding, Muscle protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	40	skeletal muscle: 12562.8;tongue: 3158.3	Cell type enriched	Detected in some	39	Skeletal myocytes: 2217.0	Group enriched	Detected in many	5	head and neck cancer: 9.6;prostate cancer: 3.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	9	Sarcoma: 201.8	Skeletal muscle - Skeletal myocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli					74000		Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm	Nucleoli	HPA028190: AB_10600831	unprognostic (2.82e-2)	unprognostic (2.27e-1)	unprognostic (2.91e-1)	unprognostic (5.39e-2)	unprognostic (2.31e-2)	prognostic unfavorable (9.27e-4)	unprognostic (1.93e-2)	unprognostic (2.37e-1)	unprognostic (4.25e-1)	unprognostic (3.81e-2)	unprognostic (1.75e-1)	unprognostic (2.92e-2)	unprognostic (1.05e-2)	unprognostic (2.59e-2)	unprognostic (3.52e-1)	unprognostic (2.11e-1)	unprognostic (1.71e-1)	Skeletal myocytes
PCNT	KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4	ENSG00000160299	Pericentrin	O95613	21	46324141-46445769	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Calmodulin-binding	Dwarfism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	skeletal muscle: 239.2	Cell type enriched	Detected in many	8	Skeletal myocytes: 378.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Group enriched	Detected in many	6	dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8	Low cancer specificity	Detected in all			Testis - Spermatocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016820, HPA019887, HPA032101	Approved		Supported	Centriolar satellite,Centrosome,Cytosol						Cluster 16: MAIT-cells - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 27: Skeletal myocytes - Muscle contraction	Centrosome	Centriolar satellite, Cytosol	HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151	unprognostic (9.07e-2)	unprognostic (1.01e-1)	unprognostic (1.65e-2)	unprognostic (1.30e-2)	unprognostic (5.35e-2)	unprognostic (3.40e-3)	unprognostic (1.27e-2)	unprognostic (2.59e-1)	unprognostic (9.29e-2)	unprognostic (1.35e-2)	unprognostic (1.59e-3)	unprognostic (3.86e-2)	unprognostic (1.95e-2)	unprognostic (5.83e-2)	unprognostic (2.90e-1)	unprognostic (3.36e-1)	unprognostic (5.86e-2)	Skeletal myocytes
IP6K3	IHPK3, INSP6K3	ENSG00000161896	Inositol hexakisphosphate kinase 3	Q96PC2	6	33721662-33746905	Enzymes, Metabolic proteins, Predicted intracellular proteins		Kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	skeletal muscle: 308.1;tongue: 83.3	Cell type enriched	Detected in some	5	Skeletal myocytes: 74.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Sarcoma: 4.0;testis cancer: 5.3		Low region specificity	Detected in some			Not detected	Not detected			HPA053644, HPA062531	Enhanced		Approved	Nucleoplasm,Cytosol		Yes					Cluster 80: Striated muscle - Unknown function	Cluster 42: Sarcoma - Muscle contraction	Cluster 11: Non-specific - Transcription	Nucleoplasm	Cytosol	HPA053644: AB_2682214, HPA062531: 	unprognostic (3.23e-2)	unprognostic (2.87e-1)	unprognostic (2.07e-5)	unprognostic (1.07e-3)	unprognostic (2.20e-1)	unprognostic (5.10e-3)	unprognostic (1.38e-1)	unprognostic (1.75e-1)	unprognostic (2.45e-1)	unprognostic (2.47e-2)	unprognostic (1.24e-2)	unprognostic (2.94e-3)	prognostic unfavorable (6.09e-4)	unprognostic (1.63e-2)	unprognostic (2.01e-1)	unprognostic (2.66e-3)	unprognostic (1.33e-1)	Skeletal myocytes
ANKRD23	DARP, FLJ32449, MARP3	ENSG00000163126	Ankyrin repeat domain 23	Q86SG2	2	96824526-96857934	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	39	skeletal muscle: 1438.6;tongue: 448.6	Cell type enriched	Detected in many	8	Skeletal myocytes: 55.4	Not detected	Not detected			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many				Low region specificity	Detected in many							HPA036201	Approved		Approved	Nucleoplasm,Actin filaments,Cytosol							Cluster 33: Striated muscle - Muscle contraction	Cluster 44: Myeloma - Humoral immune response	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm, Cytosol	Actin filaments	HPA036201: AB_10673347	unprognostic (2.48e-1)	unprognostic (7.83e-4)	unprognostic (4.93e-4)	unprognostic (1.21e-2)	unprognostic (4.28e-1)	unprognostic (3.28e-1)	unprognostic (3.27e-2)	unprognostic (6.66e-2)	unprognostic (2.46e-2)	unprognostic (3.59e-2)	unprognostic (1.81e-4)	unprognostic (1.43e-1)	unprognostic (2.04e-6)	unprognostic (2.70e-1)	unprognostic (1.39e-1)	unprognostic (1.54e-1)	unprognostic (2.70e-4)	Skeletal myocytes
TMOD4	Sk-Tmod	ENSG00000163157	Tropomodulin 4	Q9NZQ9	1	151169986-151176284	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	68	skeletal muscle: 1225.0;tongue: 534.1	Cell type enriched	Detected in some	65	Skeletal myocytes: 210.8	Not detected	Not detected			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Low region specificity	Detected in some			HPA028203	Enhanced									Cluster 24: B-cells - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 44: Myeloma - Humoral immune response	Cluster 27: Skeletal myocytes - Muscle contraction			HPA028203: AB_10600830																		Skeletal myocytes
CA3	CAIII, Car3	ENSG00000164879	Carbonic anhydrase 3	P07451	8	85373436-85449040	Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins		Lyase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	skeletal muscle: 5273.7	Cell type enriched	Detected in many	18	Skeletal myocytes: 3139.5	Group enriched	Detected in many	7	glioma: 23.1;prostate cancer: 9.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	Kidney cancer: 9.7;Sarcoma: 6.3	Prostate - Fibroblasts, Skeletal muscle - Skeletal myocytes, Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB004967, HPA021775, HPA026700	Enhanced								53000000		Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction			CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991	prognostic favorable (4.24e-6)	unprognostic (1.40e-1)	unprognostic (1.50e-2)	unprognostic (2.22e-3)	unprognostic (4.71e-2)	unprognostic (8.43e-3)	unprognostic (3.56e-2)	unprognostic (4.04e-2)	unprognostic (1.11e-1)	unprognostic (3.68e-1)	unprognostic (4.71e-2)	unprognostic (3.54e-1)	unprognostic (3.19e-2)	unprognostic (1.18e-1)	unprognostic (9.96e-2)	unprognostic (1.39e-1)	unprognostic (2.19e-1)	Skeletal myocytes
MSS51	FLJ39565, ZMYND17	ENSG00000166343	MSS51 mitochondrial translational activator	Q4VC12	10	73423579-73433561	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	skeletal muscle: 261.3	Cell type enriched	Detected in some	4	Skeletal myocytes: 53.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA038564			Uncertain	Vesicles,Cytosol							Cluster 33: Striated muscle - Muscle contraction	Cluster 52: Spermatids - Smell perception	Cluster 27: Skeletal myocytes - Muscle contraction	Vesicles	Cytosol	HPA038564: AB_10674687	unprognostic (2.49e-2)	unprognostic (2.07e-1)	unprognostic (1.40e-3)	unprognostic (2.06e-1)	unprognostic (3.21e-2)	unprognostic (1.62e-3)	unprognostic (3.05e-3)	unprognostic (7.88e-3)	unprognostic (1.98e-2)	unprognostic (3.78e-2)	unprognostic (1.50e-4)	unprognostic (1.22e-1)	unprognostic (1.78e-7)	unprognostic (1.51e-1)	unprognostic (2.60e-1)	unprognostic (2.67e-1)	unprognostic (1.55e-2)	Skeletal myocytes
RRAD	RAD, REM3	ENSG00000166592	RRAD, Ras related glycolysis inhibitor and calcium channel regulator	P55042	16	66921679-66925536	Predicted intracellular proteins		Calmodulin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	5	heart muscle: 305.8;skeletal muscle: 769.7	Cell type enriched	Detected in many	4	Skeletal myocytes: 2243.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	5	Kidney cancer: 123.4		Low region specificity	Detected in many			Low region specificity	Detected in many			HPA041755	Uncertain		Approved	Nucleoplasm,Golgi apparatus,Plasma membrane							Cluster 59: Non-specific - Translation	Cluster 68: Kidney - Mixed function	Cluster 27: Skeletal myocytes - Muscle contraction	Plasma membrane	Nucleoplasm, Golgi apparatus	HPA041755: AB_2677655	unprognostic (1.40e-2)	unprognostic (2.78e-2)	unprognostic (9.77e-2)	unprognostic (3.84e-2)	unprognostic (1.36e-2)	unprognostic (1.11e-1)	unprognostic (3.74e-2)	unprognostic (2.37e-1)	unprognostic (1.66e-1)	unprognostic (2.46e-2)	unprognostic (2.12e-2)	unprognostic (1.08e-1)	unprognostic (2.06e-3)	unprognostic (3.46e-2)	unprognostic (3.33e-2)	unprognostic (2.04e-2)	unprognostic (4.80e-3)	Skeletal myocytes
PPDPFL	C8orf22	ENSG00000168333	Pancreatic progenitor cell differentiation and proliferation factor like	Q8WWR9	8	49054311-49076093	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Tissue enriched	Detected in some	8	skeletal muscle: 948.1	Cell type enriched	Detected in some	37	Skeletal myocytes: 198.9	Group enriched	Detected in some	9	glioma: 0.7;renal cancer: 2.9	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		Leukemia: 1.0										HPA060329	Uncertain										Cluster 33: Striated muscle - Muscle contraction	Cluster 32: Myeloid leukemia - Oxygen transport	Cluster 27: Skeletal myocytes - Muscle contraction			HPA060329: AB_2684255					unprognostic (6.33e-2)							unprognostic (2.72e-1)	prognostic unfavorable (2.06e-10)					Skeletal myocytes
MYL1		ENSG00000168530	Myosin light chain 1	P05976	2	210290150-210315174	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	88	skeletal muscle: 21805.2;tongue: 15591.3	Cell type enriched	Detected in some	3800	Skeletal myocytes: 6467.0	Group enriched	Detected in some	18	head and neck cancer: 36.0;prostate cancer: 12.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	65	Sarcoma: 39.7	Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes	Region enriched	Detected in single	4	olfactory bulb: 4.0	Low region specificity	Detected in all			HPA046859, HPA063034, HPA073827	Enhanced				Intracellular and membrane				21000000		Cluster 13: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction			HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: 						prognostic unfavorable (6.59e-4)									unprognostic (1.88e-1)			Skeletal myocytes
GDNF	ATF1, ATF2, HFB1-GDNF	ENSG00000168621	Glial cell derived neurotrophic factor	P39905	5	37812677-37840041	Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins		Growth factor	Cancer-related genes, Disease variant, Hirschsprung disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 8.2;skeletal muscle: 10.1	Cell type enriched	Detected in some	49	Skeletal myocytes: 109.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		skin cancer: 20.9;testis cancer: 12.6	Heart muscle - Fibroblasts	Region enhanced	Detected in single		basal ganglia: 2.8	Low region specificity	Detected in some			CAB005210, HPA070283	Supported		Approved	Nucleoplasm,Vesicles	Secreted in other tissues						Cluster 80: Striated muscle - Unknown function	Cluster 33: Skin cancer - Membrane components	Cluster 27: Skeletal myocytes - Muscle contraction	Vesicles	Nucleoplasm	CAB005210: AB_2247684, HPA070283: AB_2686246	unprognostic (1.08e-1)	unprognostic (6.30e-2)	unprognostic (3.54e-2)	unprognostic (8.87e-2)	unprognostic (1.09e-1)	unprognostic (1.08e-1)	unprognostic (5.33e-2)	unprognostic (1.92e-1)	unprognostic (3.71e-2)	unprognostic (2.01e-2)	unprognostic (2.41e-1)	unprognostic (2.10e-1)	unprognostic (1.16e-4)	unprognostic (2.04e-1)	unprognostic (8.86e-2)	unprognostic (1.05e-1)	unprognostic (4.42e-2)	Skeletal myocytes
CALML6	CAGLP	ENSG00000169885	Calmodulin like 6	Q8TD86	1	1915108-1917296	Predicted intracellular proteins, RAS pathway related proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	19	skeletal muscle: 154.6;tongue: 109.9	Cell type enriched	Detected in single	656	Skeletal myocytes: 385.0	Not detected	Not detected			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Skeletal muscle - Skeletal myocytes																				Cluster 13: Striated muscle - Muscle contraction	Cluster 23: B-cell cancers - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction				unprognostic (3.85e-2)	unprognostic (3.04e-2)	unprognostic (1.59e-4)	unprognostic (1.66e-1)	unprognostic (3.06e-2)	unprognostic (1.01e-1)	unprognostic (1.17e-1)	unprognostic (1.33e-3)	unprognostic (9.72e-2)	unprognostic (2.04e-1)	unprognostic (3.03e-2)	unprognostic (9.76e-2)	unprognostic (5.21e-10)	unprognostic (5.06e-3)	unprognostic (1.93e-1)	unprognostic (1.23e-2)	unprognostic (6.48e-2)	Skeletal myocytes
VGLL2		ENSG00000170162	Vestigial like family member 2	Q8N8G2	6	117265558-117273565	Predicted intracellular proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	skeletal muscle: 129.4	Cell type enriched	Detected in some	12	Skeletal myocytes: 32.7	Cancer enhanced	Detected in single		glioma: 0.5	Region enhanced	Detected in some		thalamus: 2.3	Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	ovarian cancer: 25.3;Sarcoma: 10.7	Testis - Spermatogonia	Not detected	Not detected			Low region specificity	Detected in single														Cluster 33: Striated muscle - Muscle contraction	Cluster 34: Rabdoid cancer - Embryonic development	Cluster 27: Skeletal myocytes - Muscle contraction								unprognostic (3.02e-2)	unprognostic (3.09e-2)				unprognostic (1.75e-1)					unprognostic (4.92e-1)			Skeletal myocytes
KLHL38	C8ORFK36	ENSG00000175946	Kelch like family member 38	Q2WGJ6	8	123645527-123652950	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 56.7;skeletal muscle: 268.3;tongue: 76.9	Cell type enriched	Detected in single	13	Skeletal myocytes: 4.9	Group enriched	Detected in some	5	breast cancer: 1.3;melanoma: 1.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		skin cancer: 1.0	Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes	Low region specificity	Detected in single			Not detected	Not detected			HPA024770, HPA027115	Uncertain		Approved	Nucleoplasm,Cytosol		Yes					Cluster 13: Striated muscle - Muscle contraction	Cluster 65: Breast cancer - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm	Cytosol	HPA024770: AB_10599286, HPA027115: AB_10599950	unprognostic (8.62e-3)	unprognostic (3.86e-3)	unprognostic (1.02e-2)	unprognostic (8.94e-2)	unprognostic (4.68e-1)	unprognostic (2.09e-2)	unprognostic (8.20e-2)	unprognostic (2.13e-1)	unprognostic (1.54e-1)	unprognostic (4.02e-1)	unprognostic (1.19e-1)	unprognostic (5.77e-2)	unprognostic (5.73e-6)	unprognostic (8.46e-3)	unprognostic (3.82e-2)	unprognostic (6.52e-2)	unprognostic (2.84e-2)	Skeletal myocytes
TRIM72	MG53	ENSG00000177238	Tripartite motif containing 72	Q6ZMU5	16	31214091-31231537	Predicted intracellular proteins, Transporters	Exocytosis, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	skeletal muscle: 151.8;tongue: 43.0	Cell type enriched	Detected in some	13	Skeletal myocytes: 134.6	Cancer enhanced	Detected in some		head and neck cancer: 0.9	Region enriched	Detected in many	7	cerebellum: 9.3	Low immune cell specificity	Detected in some			Low lineage specificity	Detected in single			Cancer enhanced	Detected in some		Myeloma: 12.1;Sarcoma: 9.2		Not detected	Not detected			Low region specificity	Detected in all			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles						Cluster 17: Basophils - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Vesicles	Nucleoplasm	HPA054909: AB_2682639	unprognostic (2.61e-1)	unprognostic (3.21e-3)	unprognostic (5.07e-2)	unprognostic (9.77e-2)	unprognostic (3.71e-1)	unprognostic (3.13e-1)	unprognostic (2.01e-3)	unprognostic (2.80e-1)	unprognostic (6.57e-2)	unprognostic (4.90e-1)	unprognostic (1.90e-1)	unprognostic (2.49e-2)	unprognostic (2.24e-10)	unprognostic (7.70e-2)	unprognostic (6.72e-2)	unprognostic (4.15e-1)	unprognostic (4.30e-4)	Skeletal myocytes
NHLH2	bHLHa34, HEN2, NSCL2	ENSG00000177551	Nescient helix-loop-helix 2	Q02577	1	115836377-115843917	Predicted intracellular proteins, Transcription factors	Differentiation, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 7.4;esophagus: 2.3;retina: 2.1;skin 1: 3.3	Cell type enriched	Detected in some	5	Skeletal myocytes: 69.3	Not detected	Not detected			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	4	Neuroblastoma: 7.7	Prostate - Urothelial cells, Skin - Keratinocyte (other)	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA055238	Uncertain		Approved	Nucleoplasm,Nuclear bodies		Yes					Cluster 27: Brain & Skin - Unknown function	Cluster 7: Neuronal cell lines - Stereocilium	Cluster 27: Skeletal myocytes - Muscle contraction	Nuclear bodies	Nucleoplasm	HPA055238: AB_2682752	unprognostic (2.20e-2)	unprognostic (2.28e-1)		unprognostic (1.97e-1)	unprognostic (1.82e-1)	unprognostic (2.17e-1)		unprognostic (1.58e-1)	unprognostic (4.82e-2)		unprognostic (1.11e-2)	unprognostic (5.26e-2)	unprognostic (9.55e-2)	unprognostic (2.80e-3)	unprognostic (1.53e-1)	unprognostic (3.09e-1)	unprognostic (2.25e-1)	Skeletal myocytes
YIPF7	FinGER9, FLJ39576	ENSG00000177752	Yip1 domain family member 7	Q8N8F6	4	44622065-44678556	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	skeletal muscle: 84.9;tongue: 27.9	Cell type enriched	Detected in some	5	Skeletal myocytes: 25.7	Not detected	Not detected			Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Skeletal muscle - Skeletal myocytes	Not detected	Not detected							HPA030642	Uncertain									Cluster 47: Plasmacytoid DCs - Protein folding	Cluster 33: Striated muscle - Muscle contraction	Cluster 41: Non-specific - Cilium assembly	Cluster 27: Skeletal myocytes - Muscle contraction			HPA030642: AB_10601027	unprognostic (9.41e-4)	unprognostic (2.27e-1)		unprognostic (2.90e-2)	unprognostic (2.24e-1)	unprognostic (2.63e-2)		unprognostic (1.34e-1)	unprognostic (9.46e-2)	unprognostic (9.81e-2)	unprognostic (2.32e-2)	unprognostic (3.05e-2)	unprognostic (1.52e-2)	unprognostic (2.46e-2)	unprognostic (1.35e-1)	unprognostic (4.73e-2)	unprognostic (2.98e-2)	Skeletal myocytes
MYOZ1	CS-2, FATZ, MYOZ	ENSG00000177791	Myozenin 1	Q9NP98	10	73631612-73641474	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	82	skeletal muscle: 7134.0;tongue: 3308.1	Cell type enriched	Detected in some	179	Skeletal myocytes: 2089.3	Cancer enhanced	Detected in many		head and neck cancer: 7.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	6	testis cancer: 7.2	Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Skeletal muscle - Skeletal myocytes	Region enriched	Detected in single	17	olfactory bulb: 3.9	Low region specificity	Detected in all			HPA037848, HPA038437	Enhanced								71000		Cluster 33: Striated muscle - Muscle contraction	Cluster 6: BEWO - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction			HPA037848: AB_10670156, HPA038437: AB_2676009	unprognostic (4.55e-2)	unprognostic (2.23e-1)	unprognostic (4.90e-2)	unprognostic (3.91e-2)	unprognostic (1.14e-1)	unprognostic (5.08e-2)	unprognostic (2.76e-2)	unprognostic (1.22e-4)	unprognostic (1.18e-1)	unprognostic (9.25e-2)	unprognostic (2.55e-2)	unprognostic (5.59e-2)	unprognostic (5.14e-2)	unprognostic (2.64e-2)	unprognostic (6.78e-2)	unprognostic (7.17e-2)	unprognostic (1.09e-1)	Skeletal myocytes
TMEM52		ENSG00000178821	Transmembrane protein 52	Q8NDY8	1	1917590-1919279	Predicted intracellular proteins, Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Group enriched	Detected in many	5	pancreas: 216.2;skeletal muscle: 298.9;tongue: 207.8	Cell type enriched	Detected in many	5	Skeletal myocytes: 230.6	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Lung - Respiratory ciliated cells, Stomach - Chief cells	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA079372			Approved	Nucleoplasm,Plasma membrane	Intracellular and membrane					Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 59: Non-specific - Translation	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm, Plasma membrane		HPA079372: 	unprognostic (4.39e-2)	unprognostic (2.60e-1)	unprognostic (3.76e-2)	unprognostic (7.35e-3)	unprognostic (1.04e-5)	unprognostic (1.46e-1)	unprognostic (6.71e-3)	unprognostic (3.68e-2)	unprognostic (9.49e-2)	unprognostic (1.69e-1)	unprognostic (3.83e-3)	unprognostic (5.80e-2)	unprognostic (8.95e-2)	unprognostic (1.18e-1)	unprognostic (2.16e-1)	unprognostic (1.15e-1)	unprognostic (2.18e-2)	Skeletal myocytes
MYLPF	HUMMLC2B, MRLC2, MYL11	ENSG00000180209	Myosin light chain, phosphorylatable, fast skeletal muscle	Q96A32	16	30370934-30377991	Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	108	skeletal muscle: 19905.3;tongue: 5921.7	Cell type enriched	Detected in many	412	Skeletal myocytes: 9661.9	Cancer enhanced	Detected in many		head and neck cancer: 15.0	Not detected	Not detected			Immune cell enriched	Detected in single	73	plasmacytoid DC: 19.6	Lineage enriched	Detected in single	73	dendritic cells: 19.6	Cancer enriched	Detected in some	4	Sarcoma: 59.5	Skeletal muscle - Skeletal myocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039262, HPA055059	Enhanced								1000000	Cluster 47: Plasmacytoid DCs - Protein folding	Cluster 33: Striated muscle - Muscle contraction	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction			HPA039262: AB_2676418, HPA055059: AB_2732591	unprognostic (8.81e-3)	unprognostic (7.55e-3)	unprognostic (1.05e-2)	unprognostic (8.65e-2)	unprognostic (2.07e-2)	unprognostic (1.18e-2)	unprognostic (1.53e-1)	unprognostic (1.37e-3)	unprognostic (8.26e-4)	unprognostic (1.28e-1)	unprognostic (1.16e-2)	unprognostic (5.52e-2)	unprognostic (4.14e-4)	unprognostic (1.84e-1)	unprognostic (3.88e-1)	unprognostic (7.07e-3)	unprognostic (1.44e-2)	Skeletal myocytes
PPP1R27	DYSFIP1, toonin	ENSG00000182676	Protein phosphatase 1 regulatory subunit 27	Q86WC6	17	81833492-81835050	Predicted intracellular proteins		Protein phosphatase inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	25	skeletal muscle: 1205.9	Cell type enriched	Detected in some	15	Skeletal myocytes: 1031.3	Cancer enriched	Detected in single	10	head and neck cancer: 3.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	162	Leukemia: 67.7	Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in many			HPA042227, HPA048632	Uncertain		Approved	Plasma membrane,Cytosol							Cluster 33: Striated muscle - Muscle contraction	Cluster 66: Myeloid cells - Innate immune response	Cluster 27: Skeletal myocytes - Muscle contraction	Plasma membrane, Cytosol		HPA042227: , HPA048632: AB_2680469	unprognostic (3.35e-2)	unprognostic (1.12e-4)	unprognostic (1.48e-1)	unprognostic (1.08e-1)	unprognostic (1.29e-1)	unprognostic (1.85e-2)	unprognostic (1.37e-1)	unprognostic (2.21e-2)	unprognostic (7.07e-2)	unprognostic (1.32e-1)	unprognostic (5.38e-2)	unprognostic (8.70e-2)	unprognostic (4.98e-6)	unprognostic (7.97e-2)	unprognostic (1.21e-1)	unprognostic (2.19e-3)	unprognostic (1.30e-1)	Skeletal myocytes
MAFA	hMafA, RIPE3b1	ENSG00000182759	MAF bZIP transcription factor A	Q8NHW3	8	143419182-143430732	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Diabetes mellitus, Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	skeletal muscle: 25.6	Cell type enriched	Detected in many	5	Skeletal myocytes: 98.0	Low cancer specificity	Detected in some			Region enhanced	Detected in single		spinal cord: 2.8	Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Pancreas - Beta cells	Low region specificity	Detected in some			Low region specificity	Detected in many														Cluster 33: Striated muscle - Muscle contraction	Cluster 23: B-cell cancers - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction				unprognostic (5.92e-3)	unprognostic (9.89e-3)	unprognostic (2.81e-3)	unprognostic (1.42e-8)	unprognostic (1.75e-2)	unprognostic (8.67e-2)	unprognostic (6.08e-2)	unprognostic (5.67e-2)	unprognostic (4.41e-1)	unprognostic (3.71e-1)	unprognostic (1.37e-1)	unprognostic (1.21e-1)	unprognostic (1.68e-5)	unprognostic (2.11e-2)	unprognostic (1.00e-1)	unprognostic (3.36e-1)	unprognostic (3.38e-2)	Skeletal myocytes
NEB	NEB177D, NEM2	ENSG00000183091	Nebulin	P20929	2	151485336-151734487	Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Muscle protein	Cancer-related genes, Disease variant, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	69	skeletal muscle: 9300.2;tongue: 2495.6	Cell type enriched	Detected in many	61	Skeletal myocytes: 7633.9	Cancer enhanced	Detected in many		head and neck cancer: 3.8	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in all		Sarcoma: 12.3		Group enriched	Detected in some	6	cerebellum: 6.5;olfactory bulb: 4.0	Region enriched	Detected in some	6	cerebellum: 11.8	HPA016601	Enhanced								120000	Cluster 45: Eosinophils - Innate immune response	Cluster 33: Striated muscle - Muscle contraction	Cluster 56: Neurons - Neuronal signaling	Cluster 27: Skeletal myocytes - Muscle contraction			HPA016601: AB_1854361	unprognostic (2.40e-2)	unprognostic (6.71e-2)	unprognostic (2.13e-2)	unprognostic (2.52e-2)	unprognostic (1.20e-1)	unprognostic (1.85e-3)	unprognostic (2.54e-2)	unprognostic (1.45e-1)	unprognostic (4.41e-2)	unprognostic (1.73e-1)	unprognostic (1.40e-1)	unprognostic (1.07e-1)	unprognostic (4.45e-13)	unprognostic (6.80e-2)	unprognostic (2.22e-2)	unprognostic (4.07e-3)	unprognostic (4.06e-2)	Skeletal myocytes
FHL3	SLIM2	ENSG00000183386	Four and a half LIM domains 3	Q13643	1	37996770-38005606	Predicted intracellular proteins	Transcription, Transcription regulation	Activator		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	26	skeletal muscle: 1603.0;tongue: 805.6	Cell type enriched	Detected in many	9	Skeletal myocytes: 348.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Immune cell enriched	Detected in many	10	eosinophil: 336.1	Lineage enriched	Detected in many	12	granulocytes: 336.1	Low cancer specificity	Detected in many			Adipose visceral - Adipose progenitor cells	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA045723			Approved	Nucleoplasm						Cluster 45: Eosinophils - Innate immune response	Cluster 33: Striated muscle - Muscle contraction	Cluster 66: Myeloid cells - Innate immune response	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm		HPA045723: AB_10966278	prognostic favorable (5.62e-4)	unprognostic (1.12e-1)	unprognostic (3.02e-3)	unprognostic (6.97e-2)	unprognostic (2.26e-1)	unprognostic (1.88e-2)	prognostic unfavorable (8.59e-5)	unprognostic (1.02e-3)	unprognostic (1.80e-1)	unprognostic (1.36e-1)	unprognostic (9.05e-2)	unprognostic (5.05e-2)	prognostic unfavorable (4.20e-11)	unprognostic (8.88e-3)	unprognostic (2.38e-1)	unprognostic (4.94e-2)	unprognostic (2.77e-2)	Skeletal myocytes
PGPEP1L		ENSG00000183571	Pyroglutamyl-peptidase I like	A6NFU8	15	98968229-99007792	Enzymes, Predicted intracellular proteins		Hydrolase, Protease, Thiol protease		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Tissue enriched	Detected in some	4	skeletal muscle: 30.9	Cell type enriched	Detected in some	6	Skeletal myocytes: 29.7	Not detected	Not detected			Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Leukemia: 1.0;Myeloma: 1.1	Adipose subcutaneous - Smooth muscle cells	Low region specificity	Detected in all			Low region specificity	Detected in some			HPA041781	Uncertain									Cluster 46: Basophils - DNA binding	Cluster 33: Striated muscle - Muscle contraction	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction			HPA041781: AB_10795642	unprognostic (2.48e-1)	unprognostic (2.82e-2)		unprognostic (8.26e-2)	unprognostic (2.43e-3)	unprognostic (7.18e-2)		unprognostic (3.99e-2)	unprognostic (1.69e-1)	unprognostic (5.44e-2)	unprognostic (9.78e-2)	unprognostic (1.58e-1)	unprognostic (4.53e-3)	unprognostic (1.86e-1)	unprognostic (2.62e-1)	unprognostic (2.00e-2)	unprognostic (1.65e-1)	Skeletal myocytes
SRPK3	MSSK1, STK23	ENSG00000184343	SRSF protein kinase 3	Q9UPE1	X	153776412-153785732	Enzymes, Metabolic proteins, Predicted intracellular proteins	Differentiation, Myogenesis	Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		skeletal muscle: 211.4;tongue: 76.8	Cell type enriched	Detected in some	7	Skeletal myocytes: 141.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Heart muscle - Cardiomyocytes, Stomach - Fibroblasts	Low region specificity	Detected in many			Low region specificity	Detected in many													Cluster 3: Plasmacytoid DCs - Unknown function	Cluster 80: Striated muscle - Unknown function	Cluster 17: RS4;11 - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction				unprognostic (1.79e-3)	unprognostic (6.21e-2)	unprognostic (1.79e-2)	unprognostic (7.24e-2)	unprognostic (1.44e-1)	unprognostic (2.51e-1)	unprognostic (1.97e-1)	unprognostic (4.47e-4)	unprognostic (2.83e-1)	unprognostic (1.71e-1)	unprognostic (4.10e-4)	unprognostic (8.70e-2)	unprognostic (5.38e-7)	unprognostic (1.97e-2)	unprognostic (1.97e-1)	unprognostic (3.83e-2)	unprognostic (1.07e-4)	Skeletal myocytes
STAC3	MGC2793	ENSG00000185482	SH3 and cysteine rich domain 3	Q96MF2	12	57243453-57251188	Disease related genes, Human disease related genes, Predicted intracellular proteins			Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	40	skeletal muscle: 2315.3;tongue: 1169.0	Cell type enriched	Detected in many	14	Skeletal myocytes: 684.9	Cancer enhanced	Detected in all		head and neck cancer: 11.6	Low region specificity	Detected in all			Immune cell enhanced	Detected in some		intermediate monocyte: 5.8	Group enriched	Detected in many	6	dendritic cells: 3.6;monocytes: 5.8	Cancer enriched	Detected in many	9	Sarcoma: 198.7	Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Stomach - Macrophages, Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA039285, HPA039527			Enhanced	Nucleoplasm,Cytosol						Cluster 7: Monocytes - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Nucleoplasm	Cytosol	HPA039285: AB_2676427, HPA039527: AB_10673424	unprognostic (6.16e-2)	prognostic favorable (2.01e-4)	prognostic unfavorable (7.10e-4)	unprognostic (1.05e-2)	unprognostic (1.31e-1)	unprognostic (5.25e-2)	unprognostic (1.62e-1)	unprognostic (1.19e-1)	unprognostic (2.05e-2)	unprognostic (1.31e-1)	unprognostic (9.12e-2)	unprognostic (1.73e-1)	prognostic unfavorable (7.11e-6)	unprognostic (4.58e-2)	unprognostic (3.36e-1)	unprognostic (2.09e-1)	unprognostic (1.14e-3)	Skeletal myocytes
SMYD4	KIAA1936, ZMYND21	ENSG00000186532	SET and MYND domain containing 4	Q8IYR2	17	1779485-1830634	Predicted intracellular proteins, Predicted membrane proteins		Methyltransferase, Transferase	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	4	Skeletal myocytes: 137.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low immune cell specificity	Detected in all			Low lineage specificity	Detected in all			Low cancer specificity	Detected in all			Liver - Vascular Endothelial cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030059	Uncertain		Approved	Nucleoplasm,Golgi apparatus,Vesicles,Cytosol						Cluster 38: Basophils - Unknown function	Cluster 13: Striated muscle - Muscle contraction	Cluster 49: Non-specific - Unknown function	Cluster 64: Non-specific - Transcription	Golgi apparatus, Vesicles	Nucleoplasm, Cytosol	HPA030059: AB_2191728	unprognostic (1.45e-1)	unprognostic (2.48e-1)	unprognostic (2.47e-1)	unprognostic (4.23e-2)	unprognostic (1.13e-2)	unprognostic (3.66e-2)	unprognostic (4.03e-2)	unprognostic (1.04e-1)	unprognostic (1.79e-2)	unprognostic (4.95e-2)	unprognostic (1.83e-3)	unprognostic (9.26e-3)	unprognostic (3.63e-2)	unprognostic (1.33e-2)	unprognostic (7.35e-2)	unprognostic (1.52e-1)	unprognostic (1.18e-1)	Skeletal myocytes
DUSP29	DUPD1, DUSP27	ENSG00000188716	Dual specificity phosphatase 29	Q68J44	10	75037836-75058514	Enzymes, Predicted intracellular proteins		Hydrolase, Protein phosphatase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	skeletal muscle: 71.2	Cell type enriched	Detected in single	9	Skeletal myocytes: 3.0	Not detected	Not detected			Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Not detected	Not detected			Not detected	Not detected			HPA042964	Uncertain										Cluster 33: Striated muscle - Muscle contraction	Cluster 44: Myeloma - Humoral immune response	Cluster 27: Skeletal myocytes - Muscle contraction			HPA042964: AB_10795764						unprognostic (1.05e-2)				unprognostic (1.77e-1)					unprognostic (2.34e-1)			Skeletal myocytes
MYBPC1	ssMyBP-C	ENSG00000196091	Myosin binding protein C1	Q00872	12	101568353-101686028	Disease related genes, Human disease related genes, Predicted intracellular proteins	Cell adhesion	Actin-binding, Muscle protein	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	87	skeletal muscle: 11290.5;tongue: 5207.7	Cell type enriched	Detected in some	12	Skeletal myocytes: 2433.8	Cancer enhanced	Detected in many		prostate cancer: 33.0	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	35	Gastric cancer: 7.2;prostate cancer: 9.4	Heart muscle - Cardiomyocytes, Prostate - Prostate glandular cells, Skeletal muscle - Skeletal myocytes, Skin - Eccrine sweat gland cells, Testis - Early spermatids, Testis - Late spermatids	Group enriched	Detected in many	9	cerebellum: 39.6;olfactory bulb: 10.6	Region enhanced	Detected in many		thalamus: 6.9	HPA021004, HPA027614	Enhanced								240000		Cluster 33: Striated muscle - Muscle contraction	Cluster 19: Stomach & Colon cancer - Absorption	Cluster 27: Skeletal myocytes - Muscle contraction			HPA021004: AB_1854232, HPA027614: AB_10602711	prognostic favorable (4.76e-5)	unprognostic (7.72e-2)	unprognostic (1.09e-1)		unprognostic (1.81e-2)	unprognostic (3.33e-2)	unprognostic (4.63e-2)	unprognostic (8.67e-2)	unprognostic (2.93e-1)	unprognostic (9.98e-3)	unprognostic (2.56e-1)	unprognostic (2.55e-1)	unprognostic (1.19e-2)	unprognostic (4.10e-2)	unprognostic (7.96e-2)	unprognostic (6.13e-2)	unprognostic (5.55e-3)	Skeletal myocytes
RYR1	CCO, MHS, MHS1, PPP1R137, RYR	ENSG00000196218	Ryanodine receptor 1	P21817	19	38433691-38587564	Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	skeletal muscle: 1618.9	Cell type enriched	Detected in many	9	Skeletal myocytes: 452.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	7	intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8	Group enriched	Detected in many	8	dendritic cells: 2.9;monocytes: 3.8	Cancer enhanced	Detected in many		cervical cancer: 30.5		Low region specificity	Detected in single							HPA056416	Enhanced		Approved	Golgi apparatus,Vesicles,Cytosol					46000	Cluster 51: Monocytes - Innate immune response	Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Golgi apparatus, Vesicles	Cytosol	HPA056416: AB_2683121	unprognostic (2.22e-3)	unprognostic (1.91e-3)	unprognostic (9.59e-2)	unprognostic (5.34e-4)	unprognostic (2.50e-1)	unprognostic (6.00e-2)	unprognostic (2.11e-1)	unprognostic (1.06e-1)	unprognostic (1.18e-1)	unprognostic (3.20e-3)	unprognostic (3.52e-1)	unprognostic (2.35e-1)	unprognostic (1.07e-5)	unprognostic (1.13e-2)	unprognostic (8.10e-2)	unprognostic (6.62e-3)	unprognostic (1.34e-1)	Skeletal myocytes
ATP2A1	ATP2A, SERCA1	ENSG00000196296	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1	O14983	16	28878405-28904466	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Calcium transport, Ion transport, Transport	Translocase	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	85	skeletal muscle: 8241.7;tongue: 3199.6	Cell type enriched	Detected in some	113	Skeletal myocytes: 637.4	Cancer enhanced	Detected in many		head and neck cancer: 4.7	Low region specificity	Detected in many			Immune cell enhanced	Detected in some		NK-cell: 1.6	Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Skeletal muscle - Skeletal myocytes	Region enriched	Detected in some	8	thalamus: 13.1	Group enriched	Detected in some	6	basal ganglia: 1.3;cerebral cortex: 1.4;hippocampal formation: 1.2	CAB002310, CAB032706, HPA066701	Enhanced		Approved	Endoplasmic reticulum					2800000	Cluster 15: NK-cells - Transcription	Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Endoplasmic reticulum		CAB002310: AB_564139, CAB032706: AB_2061286, HPA066701: 	unprognostic (2.37e-1)	unprognostic (6.81e-2)	unprognostic (2.23e-5)	unprognostic (5.35e-2)	unprognostic (2.27e-1)	unprognostic (2.04e-1)	unprognostic (1.89e-1)	unprognostic (1.19e-1)	unprognostic (5.24e-2)	unprognostic (1.87e-1)	unprognostic (5.22e-2)	unprognostic (4.94e-2)	unprognostic (2.72e-4)	unprognostic (1.70e-2)	unprognostic (1.91e-1)	unprognostic (1.49e-1)	unprognostic (2.51e-2)	Skeletal myocytes
CHRNG	ACHRG	ENSG00000196811	Cholinergic receptor nicotinic gamma subunit	P07510	2	232539692-232548115	Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	skeletal muscle: 32.0	Cell type enriched	Detected in some	42	Skeletal myocytes: 52.5	Cancer enhanced	Detected in single		head and neck cancer: 0.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	17	Sarcoma: 6.8		Not detected	Not detected			Not detected	Not detected													Cluster 15: NK-cells - Transcription	Cluster 33: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction				unprognostic (2.26e-1)	unprognostic (8.97e-2)	unprognostic (5.61e-2)	unprognostic (1.92e-2)	unprognostic (4.38e-1)	unprognostic (4.86e-3)	unprognostic (2.32e-1)	unprognostic (1.06e-2)	unprognostic (1.04e-1)	unprognostic (1.70e-1)	unprognostic (4.18e-2)	unprognostic (4.32e-1)	unprognostic (4.19e-6)	unprognostic (6.13e-2)	unprognostic (8.66e-2)	unprognostic (1.86e-1)	unprognostic (3.24e-2)	Skeletal myocytes
OR14J1	hs6M1-28, OR5U1	ENSG00000204695	Olfactory receptor family 14 subfamily J member 1	Q9UGF5	6	29301701-29313017	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Tissue enhanced	Detected in some		brain: 5.2;retina: 2.0	Cell type enriched	Detected in single	6	Skeletal myocytes: 2.0	Not detected	Not detected			Low region specificity	Detected in many			Immune cell enhanced	Detected in single		basophil: 1.1	Low lineage specificity	Detected in single			Low cancer specificity	Detected in some			Testis - Early spermatids	Not detected	Not detected			Not detected	Not detected													Cluster 42: Non-specific - Transcription	Cluster 6: Brain - Smell perception	Cluster 52: Spermatids - Smell perception	Cluster 27: Skeletal myocytes - Muscle contraction																					Skeletal myocytes
SMTNL1	CHASM	ENSG00000214872	Smoothelin like 1	A8MU46	11	57542641-57550274	Predicted intracellular proteins		Calmodulin-binding, Muscle protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	51	skeletal muscle: 711.3;tongue: 192.9	Cell type enriched	Detected in some	71	Skeletal myocytes: 78.2	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Low immune cell specificity	Detected in single			Low lineage specificity	Detected in single			Low cancer specificity	Detected in some			Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Not detected	Not detected													Cluster 5: Granulocytes - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 30: Non-specific - Antiviral immune response	Cluster 27: Skeletal myocytes - Muscle contraction				unprognostic (1.35e-2)	unprognostic (3.90e-1)	unprognostic (1.10e-1)	unprognostic (1.79e-3)	unprognostic (3.09e-1)	unprognostic (1.66e-1)	unprognostic (2.22e-1)	unprognostic (8.41e-2)	unprognostic (1.41e-1)	unprognostic (3.53e-3)	unprognostic (4.04e-2)	unprognostic (2.68e-2)	unprognostic (1.04e-6)	unprognostic (1.21e-1)	unprognostic (1.10e-1)	unprognostic (4.49e-1)	unprognostic (1.44e-2)	Skeletal myocytes
KLHL41	KBTBD10, Krp1, SARCOSIN	ENSG00000239474	Kelch like family member 41	O60662	2	169509702-169526258	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins			Disease variant, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	42	skeletal muscle: 5038.6;tongue: 3473.7	Cell type enriched	Detected in some	12	Skeletal myocytes: 1774.6	Group enriched	Detected in some	9	head and neck cancer: 10.8;prostate cancer: 3.3	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	11	Sarcoma: 17.8	Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA021165, HPA021753, HPA021760	Enhanced		Supported	Nucleoplasm,Plasma membrane,Cytosol							Cluster 13: Striated muscle - Muscle contraction	Cluster 42: Sarcoma - Muscle contraction	Cluster 27: Skeletal myocytes - Muscle contraction	Cytosol	Nucleoplasm, Plasma membrane	HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091	unprognostic (2.44e-2)	unprognostic (6.12e-2)	unprognostic (9.01e-2)	unprognostic (2.94e-2)	unprognostic (2.90e-1)	unprognostic (1.36e-3)	unprognostic (2.05e-1)	unprognostic (5.46e-3)	unprognostic (1.88e-1)	unprognostic (5.38e-2)	unprognostic (6.65e-4)	unprognostic (9.64e-2)	unprognostic (1.50e-1)	unprognostic (1.69e-3)	unprognostic (1.19e-1)	unprognostic (1.12e-2)	unprognostic (1.52e-1)	Skeletal myocytes
STRIT1	DWORF	ENSG00000240045	Small transmembrane regulator of ion transport 1	P0DN84	3	155290227-155293683	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	79	skeletal muscle: 1711.3;tongue: 698.4	Cell type enriched	Detected in some	51	Skeletal myocytes: 347.4	Cancer enhanced	Detected in some		head and neck cancer: 1.1;prostate cancer: 1.3	Low region specificity	Detected in all			Immune cell enriched	Detected in single	7	basophil: 1.0	Lineage enriched	Detected in single	10	granulocytes: 1.0	Low cancer specificity	Detected in single			Kidney - Proximal tubular cells																			Cluster 34: Basophils - Unknown function	Cluster 33: Striated muscle - Muscle contraction	Cluster 2: DU4475 - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction							unprognostic (6.77e-4)		unprognostic (1.60e-2)					unprognostic (6.62e-2)	unprognostic (1.58e-1)	unprognostic (7.82e-3)	unprognostic (1.33e-2)				Skeletal myocytes
ACTN3		ENSG00000248746	Actinin alpha 3	Q08043	11	66546395-66563334	Plasma proteins, Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	72	skeletal muscle: 1670.4	Cell type enriched	Detected in some	6	Skeletal myocytes: 115.8	Cancer enriched	Detected in single	5	testis cancer: 0.5	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	ovarian cancer: 2.3;Rhabdoid: 5.3	Skeletal muscle - Skeletal myocytes, Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA006035	Uncertain		Approved	Actin filaments,Cytosol					11000000		Cluster 33: Striated muscle - Muscle contraction	Cluster 22: Rhabdoid cancers - Neuronal signaling	Cluster 27: Skeletal myocytes - Muscle contraction	Actin filaments	Cytosol	HPA006035: AB_1078095	unprognostic (2.54e-1)	unprognostic (1.07e-1)	unprognostic (6.16e-2)	unprognostic (1.46e-1)	unprognostic (1.70e-1)	unprognostic (3.35e-4)	unprognostic (1.40e-3)	unprognostic (5.37e-3)	unprognostic (5.09e-3)	unprognostic (1.19e-1)	unprognostic (1.17e-1)	unprognostic (1.66e-2)	unprognostic (6.71e-9)	unprognostic (2.06e-1)	unprognostic (6.98e-2)	unprognostic (5.16e-2)	unprognostic (2.48e-1)	Skeletal myocytes
PCDHGA4	PCDH-GAMMA-A4	ENSG00000262576	Protocadherin gamma subfamily A, 4	Q9Y5G9	5	141355021-141512975	Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in single	6	Skeletal myocytes: 4.0	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Lung - Fibroblast_1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA008755, HPA010580	Uncertain		Uncertain	Nucleoplasm,Vesicles,Plasma membrane,Cytosol						Cluster 16: MAIT-cells - Unknown function	Cluster 21: Non-specific - Transcription	Cluster 20: Connective tissue cells - ECM organization	Cluster 27: Skeletal myocytes - Muscle contraction	Vesicles, Plasma membrane	Nucleoplasm, Cytosol	HPA008755: AB_1079577, HPA010580: AB_2732401	unprognostic (1.27e-2)	unprognostic (4.55e-3)	unprognostic (2.00e-2)	unprognostic (6.54e-4)	unprognostic (1.87e-2)	unprognostic (1.06e-2)	unprognostic (1.02e-1)	unprognostic (1.20e-2)	unprognostic (5.62e-2)	unprognostic (3.76e-1)	unprognostic (6.31e-2)	unprognostic (1.74e-1)	unprognostic (2.94e-2)	unprognostic (1.30e-2)	unprognostic (2.30e-2)	unprognostic (1.65e-1)	unprognostic (2.31e-4)	Skeletal myocytes
MYH4	MYH2B, MyHC-2B, MyHC-IIb	ENSG00000264424	Myosin heavy chain 4	Q9Y623	17	10443290-10469559	Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in single	23	skeletal muscle: 10.6	Cell type enriched	Detected in single	29	Skeletal myocytes: 9.9	Cancer enriched	Detected in single	115	liver cancer: 9.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Skeletal muscle - Skeletal myocytes									HPA001349	Supported		Uncertain	Focal adhesion sites					86000000		Cluster 33: Striated muscle - Muscle contraction	Cluster 39: Non-specific - Unknown function	Cluster 27: Skeletal myocytes - Muscle contraction	Focal adhesion sites		HPA001349: AB_1079437	unprognostic (3.27e-2)		unprognostic (2.94e-2)			unprognostic (4.94e-2)	unprognostic (1.69e-2)	unprognostic (4.72e-1)			unprognostic (1.37e-1)		unprognostic (3.32e-2)	unprognostic (1.21e-3)	unprognostic (3.52e-4)		unprognostic (9.97e-2)	Skeletal myocytes
PRR33	C11orf89, LOC728008	ENSG00000283787	Proline rich 33		11	1888078-1891895	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level			Tissue enhanced	Detected in many		adrenal gland: 23.4;lymphoid tissue: 28.3;skeletal muscle: 35.2	Cell type enriched	Detected in some	4	Skeletal myocytes: 6.9					Not detected	Not detected			Immune cell enriched	Detected in single	6	neutrophil: 1.4	Lineage enriched	Detected in single	6	granulocytes: 1.4	Group enriched	Detected in some	13	Leukemia: 1.6;lymphoma: 5.7;Myeloma: 2.6	Adipose subcutaneous - Adipose progenitor cells, Kidney - T-cells, Stomach - Fibroblasts	Not detected	Not detected			Low region specificity	Detected in many													Cluster 50: Neutrophils - Cellular senescence	Cluster 59: Non-specific - Translation	Cluster 12: Lymphoid cancers - Adaptive immune response	Cluster 27: Skeletal myocytes - Muscle contraction																					Skeletal myocytes
